Disclaimer:
Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.
Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide Tablet 40/10/25 mg
Overview
What is Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets provided as a tablet for oral administration, are a fixed combination of olmesartan medoxomil (ARB), amlodipine (CCB), and hydrochlorothiazide (thiazide diuretic).
Olmesartan medoxomil, a prodrug, is hydrolyzed to olmesartan during absorption from the gastrointestinal tract.
The olmesartan medoxomil component of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets is chemically described as 2,3-dihydroxy-2-butenyl 4-(1-hydroxy-1- methylethyl)-2-propyl-1-[1-tetrazol-5-ylphenyl)benzyl]imidazole-5-carboxylate, cyclic 2,3-carbonate. Its empirical formula is CHNO.
The amlodipine besylate component of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets is chemically described as 3-ethyl-5-methyl (±)-2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-3,5- pyridinedicarboxylate, monobenzenesulphonate. Its empirical formula is CHCINO•CHOS.
The hydrochlorothiazide component of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets is chemically described as 6-chloro-3,4-dihydro-2-1,2,4-benzo-thiazidiazine-7-sulfonamide 1,1-dioxide. Its empirical formula is CHCINOS.
The structural formula for olmesartan medoxomil, USP is:
The structural formula for amlodipine besylate, USP is:
The structural formula for hydrochlorothiazide, USP is:
Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP a white to light yellowish-white powder or crystalline powder, amlodipine besylate, USP a white to off-white crystalline powder, and hydrochlorothiazide, USP a white or practically white, crystalline powder. The molecular weights of olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide are 558.6, 567.1, and 297.7, respectively. Olmesartan medoxomil is practically insoluble in water and sparingly soluble in methanol. Amlodipine besylate is slightly soluble in water and sparingly soluble in ethanol. Hydrochlorothiazide is slightly soluble in water but freely soluble in sodium hydroxide solution.
Each tablet of olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets also contains the following inactive ingredients: colloidal silicone dioxide, croscarmellose sodium, lactose monohydrate, magnesium stearate, maize starch, pregelatinized maize starch, silicified microcrystalline cellulose, and talc. The color coating contains opadry II pink (20/5/12.5 mg, 40/10/12.5 mg and 40/10/25 mg tablets), and opadry II yellow (40/5/12.5 mg and 40/5/25 mg tablets).
The color coating material contains the following ingredients.
What does Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg look like?
What are the available doses of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are available in the following strength combinations:
What should I talk to my health care provider before I take Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
How should I use Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets is not indicated for initial therapy.
Dose once daily. Dosage may be increased after 2 weeks to a maximum dose of 40 /10 /25 mg once daily (2).
Dose selection should be individualized based on previous therapy (2).
What interacts with Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Sorry No Records found
What are the warnings of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Sorry No Records found
What are the precautions of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Sorry No Records found
What are the side effects of Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Sorry No records found
What should I look out for while using Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Anuria: Hypersensitivity to sulfonamide-derived drugs (4).
Do not co-administer aliskiren with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in patients with diabetes (4).
What might happen if I take too much Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
There is no information on overdosage with olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets in humans.
Olmesartan medoxomil.
Amlodipine.
Overdosage might be expected to cause excessive peripheral vasodilation with marked hypotension and possibly a reflex tachycardia. In humans, experience with intentional overdosage of amlodipine is limited.
If massive overdose should occur, active cardiac and respiratory monitoring should be instituted. Frequent blood pressure measurements are essential. Should hypotension occur, cardiovascular support including elevation of the extremities and the judicious administration of fluids should be initiated. If hypotension remains unresponsive to these conservative measures, administration of vasopressors (such as phenylephrine) should be considered with attention to circulating volume and urine output. Intravenous calcium gluconate may help to reverse the effects of calcium entry blockade. As amlodipine is highly protein bound, hemodialysis is not likely to be of benefit.
Hydrochlorothiazide.
How should I store and handle Olmesartan Medoxomil, Amlodipine and Hydrochlorothiazide 20/5/12.5 mg?
Keep out of reach of children.Fluvoxamine maleate tablets, USP should be protected from high humidity and stored at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].Dispense in a tight, light-resistant container.Keep out of reach of children.Fluvoxamine maleate tablets, USP should be protected from high humidity and stored at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].Dispense in a tight, light-resistant container.Keep out of reach of children.Fluvoxamine maleate tablets, USP should be protected from high humidity and stored at 20°C to 25°C (68°F to 77°F); excursions permitted from 15°C to 30°C (59°F to 86°F) [see USP Controlled Room Temperature].Dispense in a tight, light-resistant container.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature]. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets contain olmesartan medoxomil, USP, amlodipine besylate, USP at a dose equivalent to 5 or 10 mg amlodipine, and hydrochlorothiazide, USP in the strengths described below.Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are differentiated by tablet color/size. Olmesartan medoxomil, amlodipine and hydrochlorothiazide tablets are supplied for oral administration in the following strength and package configurations:20/5/12.5 mg tablets are orange white colored, round, biconvex, film coated debossed with '26' on one side and plain on the other side.Bottles of 30 NDC 13668-397-30Bottles of 90 NDC 13668-397-90Bottles of 500 NDC 13668-397-05 100 Unit dose Tablets NDC 13668-397-7440/5/12.5 mg tablets are light yellow to yellow colored, round, biconvex, film coated debossed with '1386' on one side and plain on the other side.Bottles of 30 NDC 13668-386-30Bottles of 90 NDC 13668-386-90Bottles of 500 NDC 13668-386-05 100 Unit dose Tablets NDC 13668-386-7440/5/25 mg tablets are light yellow to yellow colored, oval shaped, biconvex, film coated debossed with '1385' on one side and plain on the other side.Bottles of 30 NDC 13668-385-30Bottles of 90 NDC 13668-385-90Bottles of 500 NDC 13668-385-05 100 Unit dose Tablets NDC 13668-385-7440/10/12.5 mg tablets are grayish red colored, round, biconvex, film coated, debossed with '1383' on one side and plain on the other side.Bottles of 30 NDC 13668-383-30Bottles of 90 NDC 13668-383-90Bottles of 500 NDC 13668-383-05 100 Unit dose Tablets NDC 13668-383-7440/10/25 mg tablets are grayish red colored, oval shaped, biconvex, film coated, debossed with '1382' on one side and plain on the other side.Bottles of 30 NDC 13668-382-30Bottles of 90 NDC 13668-382-90Bottles of 500 NDC 13668-382-05 100 Unit dose Tablets NDC 13668-382-74 Store at 20° to 25°C (68° to 77°F); excursions permitted between 15°C and 30°C (59°F and 86°F) [see USP Controlled Room Temperature].
